학술논문
Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
Document Type
Article
Author
Hensley, Kathryn S.; Jongkees, Marlou J.; Geers, Daryl; GeurtsvanKessel, Corine H.; Mueller, Yvonne M.; Dalm, Virgil A. S. H.; Papageorgiou, Grigorios; Steggink, Hanka; Gorska, Alicja; Bogers, Susanne; den Hollander, Jan G.; Bierman, Wouter F. W.; Gelinck, Luc B. S.; Schippers, Emile F.; Ammerlaan, Heidi S. M.; van der Valk, Marc; van Vonderen, Marit G. A.; Delsing, Corine E.; Gisolf, Elisabeth H.; Bruns, Anke H. W.
Source
Subject
*COVID-19 vaccines
*HIV-positive persons
*IMMUNE response
*MONONUCLEAR leukocytes
*LONGITUDINAL method
*
*
*
*
Language
ISSN
1549-1277
Abstract
Statistics performed using Wilcoxon matched-pairs signed rank test (p = 0.008); pre- and post-vaccination for Delta: ns. (B) Cellular immune response to wild-type and Delta spike in AIM assay (n = 14): percentage of CD4+ CD137+ OX40+ T-cells after subtraction of DMSO. Reference 1 Hensley KS, Jongkees MJ, Geers D, GeurtsvanKessel CH, Mueller YM, Dalm VASH, et al. (2022) Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study. [Extracted from the article]